Phathom Pharmaceuticals, Inc. (PHAT)

Typically moves ±6.47% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-10-16 APPROXIMATE

Across 28 earnings reports since Nov 25, 2019, Phathom Pharmaceuticals, Inc. (PHAT) has a clear post-earnings pattern. It moves ±6.47% on average after reporting and finishes higher 53.6% of the time. Its largest post-earnings gain was +10.06% (Feb 26, 2026) and its largest decline was -28.78% (Aug 02, 2022). The next earnings report is predicted for 2026-10-16 (approximate).

Earnings reactions

How PHAT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.47%

Positive %

53.6%

Negative %

46.4%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Jul 30, 2026	☀ PRE	-22.64%	open_in_new
Apr 30, 2026	☀ PRE	-4.92%	open_in_new
Feb 26, 2026	☀ PRE	+10.06%	open_in_new
Oct 30, 2025	☀ PRE	-1.63%	open_in_new
Aug 07, 2025	☀ PRE	+8.29%	open_in_new
May 01, 2025	☀ PRE	-21.68%	open_in_new
Mar 06, 2025	☀ PRE	-2.96%	open_in_new
Nov 07, 2024	☀ PRE	+2.78%	open_in_new
Aug 08, 2024	☀ PRE	+8.7%	open_in_new
May 09, 2024	☀ PRE	-0.1%	open_in_new
Mar 07, 2024	☀ PRE	-6.58%	open_in_new
Nov 09, 2023	☀ PRE	+0.51%	open_in_new
Aug 10, 2023	☽ POST	-0.67%	open_in_new
May 10, 2023	☀ PRE	+3.67%	open_in_new
Feb 28, 2023	☀ PRE	-11.75%	open_in_new
Nov 09, 2022	☀ PRE	-7.55%	open_in_new
Aug 02, 2022	☀ PRE	-28.78%	open_in_new
May 10, 2022	☀ PRE	-8.06%	open_in_new
Mar 01, 2022	☽ POST	+2.04%	open_in_new
Nov 08, 2021	☀ PRE	+1.43%	open_in_new
Aug 10, 2021	☀ PRE	+2.87%	open_in_new
May 11, 2021	☀ PRE	+3.4%	open_in_new
Mar 30, 2021	☽ POST	+3.44%	open_in_new
Nov 10, 2020	☽ POST	-7.93%	open_in_new
Aug 06, 2020	☀ PRE	+0.3%	open_in_new
May 12, 2020	☽ POST	+3.69%	open_in_new
Mar 19, 2020	☀ PRE	+0.11%	open_in_new
Nov 25, 2019	☀ PRE	+4.6%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.47%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 26 →

Funds holding

$212860659

Total value held

Buying

22 added · 4 reduced

Blackrock, Inc.

$49097648 +11.40%

Invesco Ltd.

$43722581 NEW BUY

Carlyle Group Inc.

$37940367 NEW BUY

Franklin Resources Inc

$21383482 +98.17%

Goldman Sachs Group Inc

$19291647 +183.94%

SEC Filing Types

description SCHEDULE 13G/A

10 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260908	open_in_new SEC.gov
10-Q	20260730	open_in_new SEC.gov
8-K	20260730	open_in_new SEC.gov
SCHEDULE 13G	20260729	open_in_new SEC.gov
SCHEDULE 13G/A	20260720	open_in_new SEC.gov
4	20260716	open_in_new SEC.gov
8-K	20260623	open_in_new SEC.gov
4	20260527	open_in_new SEC.gov
4	20260521	open_in_new SEC.gov
4	20260521	open_in_new SEC.gov

Frequently asked about PHAT earnings

When does Phathom Pharmaceuticals, Inc. report earnings next? expand_more

Phathom Pharmaceuticals, Inc. (PHAT)'s next earnings date is approximate for 2026-10-16. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does PHAT stock move after earnings? expand_more

Over 28 reports, PHAT has moved an average of ±6.47% the session after earnings, closing higher 53.6% of the time.

What was PHAT's biggest post-earnings move? expand_more

PHAT's largest post-earnings gain on record was +10.06% on Feb 26, 2026, and its largest decline was -28.78% on Aug 02, 2022.

Where can I find Phathom Pharmaceuticals, Inc.'s SEC filings? expand_more

All of Phathom Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.